Chlamydia pneumoniae infection of alveolar macrophages: A model

Journal of Infectious Diseases

Volumn 187, Issue 7, 2003, Pages 1107-1115

  Haranaga, Shusaku ^a   Yamaguchi, Hiroyuki ^a   Ikejima, Hideaki ^a   Friedman, Herman ^a   Yamamoto, Yoshimasa ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; MESSENGER RNA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CELL INCLUSION; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; CONTINUOUS CULTURE; CONTROLLED STUDY; FEMALE; GENE; HSP60 GENE; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; OMCB GENE; PRIORITY JOURNAL; RNA ANALYSIS;

ANIMALS; CELL LINE; CELLS, CULTURED; CHLAMYDOPHILA PNEUMONIAE; COLONY COUNT, MICROBIAL; FEMALE; GENE EXPRESSION; GENES, BACTERIAL; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037385111     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368168     Document Type: Article

References (35)

1. Hahn DL, Peeling RW, Dillon E, McDonald R, Saikku P. Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol 2000; 84:227-33.
2. Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 1995; 27:179-82.
3. Hammerschlag MR. The role of Chlamydia in upper respiratory tract infections. Curr Infect Dis Rep 2000; 2:115-20.
4. Jahn HU, Krull M, Wuppermann FN, et al. Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J Infect Dis 2000; 182:1678-87.
5. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64:1614-20.
6. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998; 19:721-7.
7. Dechend R, Maass M, Gieffers J, et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999; 100:1369-73.
8. Quinn TC, Gaydos CA. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am J Heart 1999; 138:S507-11.
9. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998; 66:5067-72.
10. Caignard A, Martin MS, Hammann A, Martin F. Heterogeneity of the rat macrophage antigenic specificity of resident peritoneal and pleural macrophages. Cell Mol Biol 1985; 31:41-7
11. Spiteri MA, Clarke SW, Poulter LW. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur Respir J 1992; 5:717-26.
12. Mbawuike IN, Herscowitz HB. MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J Leukoc Biol 1989; 6:119-27.
13. Sankaran K, Herscowitz HB. Phenotypic and functional heterogeneity of the murine alveolar macrophage-derived cell line MH-S. J Leukoc Biol 1995; 57:562-8.
14. Hearst JE, Warr GA, Jakab GJ. Characterization of murine lung and peritoneal macrophages. J Reticuloendothel Soc 1980; 27:443-54.
15. 2. J Clin Invest 1977; 59:443-8.
16. Airenne S, Surcel HM, Alakarppa H, Laitinen K, Paavonen J, Saikku P, Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect Immun 1999; 67:1445-9.
17. Yamamoto Y, Retzlaff C, He P, Klein TW, Friedman H. Quantitative reverse transcription-PCR analysis of Legionella pneumophila-induced cytokine mRNA in different macrophage populations by high-performance liquid chromatography. Clin Diagn Lab Immunol 1995; 2:18-24.
18. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 1995; 63:2801-3.
19. Yamaguchi H, Haranaga S, Widen R, Friedman H, Yamamoto Y. Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect Immun 2002; 70:2392-8.
20. Miyashita N, Matsumoto A. Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies. J Clin Microbiol 1992; 30:2911-6.
21. Hatch TP, Allan I, Pearce JH. Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp. J Bacteriol 1984; 157:13-20.
22. Hatch TP, Miceli M, Sublett JE. Synthesis of disulfide-bonded outer membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J Bacteriol 1986; 165:379-85.
23. Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, Hackstadt T. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol 2000; 37:913-25.
24. Perara E, Ganem D, Engel JN. A developmentally regulated chlamydial gene with apparent homology to eukaryotic histone H1. Proc Natl Acad Sci USA 1992; 89:2125-9.
25. Sardinia LM, Segal E, Ganem D. Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol 1988; 134:997-1004.
26. Gerard HC, Kohler L, Branigan PJ, Zeidler H, Schumacher HR, Hudson AP. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med Microbiol Immunol (Berl) 1998; 187:115-20.
27. Khan MA, Potter CW, Sharrard RM. A reverse transcriptase-PCR-based assay for in vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J Antimicrob Chemother 1996; 37:677-85.
28. Esposito G, Blasi F, Allegra L, et al. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg 1999; 13:421-5.
29. Gerard HC, Schumacher HR, El-Gabalawy H, Goldbach-Mansky R, Hudson AP. Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog 2000; 29:17-24.
30. Clarke IN, Ward ME, Lambden PR. Molecular cloning and sequence analysis of a developmentally regulated cysteine-rich outer membrane protein from Chlamydia trachomatis. Gene 1988; 71:307-14.
31. Wolf K, Fischer E, Hackstadt T. Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun 2000; 68:2379-85.
32. Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun 2001; 69:7927-32.
33. Mathews S, George C, Flegg C, Stenzel D, Timms P. Differential expression of ompA, ompB, pyk, nlpD, and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathog 2001; 30:337-45.
34. Byrne GI, Ouellette SP, Wang Z, et al. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun 2001; 69:5423-9.
35. Molestina RE, Klein JB, Miller RD, Pierce WH, Ramirez JA, Summersgill JT. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 2002; 70:2976-81.